Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions
- 作者：Muriel B. Sä ; ttler ; Iris Demmer ; Sarah K. Williams ; Katharina Maier ; Doron Merkler ; Ivana Gadjanski ; Christine Stadelmann ; Mathias Bä ; hr and Ricarda Diem
- 刊名：Experimental Neurology
- 出版年：2006
- 期刊代码：78_00144886
- 类别：neu
- 出版时间：September 2006
- 卷：201
- 期：1
- 页码：172-181
- 文件大小：423 K
摘要
Interferon-β-1a (IFN-β-1a) is an approved treatment for multiple sclerosis (MS). It improves the disease course by reducing the relapse rate as well as the persistent neurological deficits. Recent MRI and post-mortem studies revealed that neuronal and axonal damage are most relevant for chronic disability in MS patients. We have characterized previously time course and mechanisms of neuronal apoptosis in a rat model of myelin oligodendrocyte glycoprotein (MOG)-induced optic neuritis. In this animal model, application of IFN-β-1a three times per week slightly decreases the loss of retinal ganglion cells (RGCs), the neurons that form the axons within the optic nerve. In contrast to neurotrophic factors, this cytokine does not directly protect cultured RGCs from apoptosis. We conclude that IFN-β-1a is a suitable candidate to be combined with a directly neuroprotective agent in order to further decrease axonal and neuronal degeneration in MS patients.